Targeted News Service

Ropes & Gray Advises Vir Biotechnology in Global License Agreement With Sanofi
August 13, 2024

BOSTON, Massachusetts, Aug. 13 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray represented San Francisco-based Vir Biotechnology in an exclusive worldwide license agreement with Sanofi for three clinical stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases acquired by Sanofi from Amunix Pharmaceuticals. The transaction was announced on August 1.

Under the agreemen . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form